Biodexa Pharmaceuticals

AI Score

0

Unlock

4.18
-0.12 (-2.79%)
At close: Jan 15, 2025, 9:36 AM

Biodexa Pharmaceuticals Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for BDRX stock have an median target of 200, with a low estimate of 200 and a high estimate of 200. The median target predicts an increase of 4684.69% from the current stock price of 4.18.

Analyst Consensus: Buy
Target Low Average Median High
Price $200 $200 $200 $200
Change 4684.69% 4684.69% 4684.69% 4684.69%

AI Analyst Report

According to 1 stock analyst, the rating for Biodexa Pharmaceuticals is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Feb 24
Strong Buy 0
Buy 1
Hold 0
Sell 0
Strong Sell 0
Total 1

Financial Forecast this Year

Revenue This Year
26.38K
from 381.00K
Increased by -93.1%
Revenue Next Year
13.33K
from 26.38K
Increased by -49.5%
EPS This Year
0
from -224.13
Increased by 100.0%
EPS Next Year
0
from 0
Increased by -%